| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/05/2015 | WO2015031666A1 Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases |
| 03/05/2015 | WO2015031613A1 Biaryl acetamide compounds and methods of use thereof |
| 03/05/2015 | WO2015031562A1 PROCESS FOR THE PREPARATION OF N,N-DICYCLOPROPYL-4-(1,5-DIMETHYL-1H-PYRAZOL-3-YLAMINO)-6-ETHYL-1-METHYL-1,6-DIHYDROIMIDAZO[4,5-d]PYRROLO[2,3-b]PYRIDINE-7-CARBOXAMIDE |
| 03/05/2015 | WO2015031541A1 Novel sez6 modulators and methods of use |
| 03/05/2015 | WO2015031396A1 Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses |
| 03/05/2015 | WO2015031109A1 Inhibition of wnt, tgf beta and hippo signaling pathways to treat cancer, organ fibrosis and metabolic disorders |
| 03/05/2015 | WO2015030283A1 Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent |
| 03/05/2015 | WO2015030106A1 Compound having ggt inhibitory effect, and ggt-family enzyme inhibitor |
| 03/05/2015 | WO2015030057A1 Novel morpholine derivative or salt thereof |
| 03/05/2015 | WO2015030021A1 Pharmaceutical composition having pyrimidine compound as active ingredient |
| 03/05/2015 | WO2015029966A1 ω3 UNSATURATED FATTY ACID ENZYME AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID |
| 03/05/2015 | WO2015029051A1 Pyrazolochalcones as potential anticancer agents |
| 03/05/2015 | WO2015028960A1 Substituted heterocyclic derivatives as gpr agonists and uses thereof |
| 03/05/2015 | WO2015028929A1 Compounds and composition for use in the inhibition of the lbc-rhoa interaction, in particular for the treatment of cancer |
| 03/05/2015 | WO2015028919A1 Agent for the treatment and prevention of cancer |
| 03/05/2015 | WO2015028901A1 A nanostructure for the vehiculation of gas and/or active ingredients and/or contrast agents and uses thereof |
| 03/05/2015 | WO2015028850A1 Novel cytotoxic agents for conjugation of drugs to cell binding molecule |
| 03/05/2015 | WO2015028848A1 Bicyclic heterocyclic compounds as multi-kinase inhibitors |
| 03/05/2015 | WO2015028828A1 Sorafenib salts |
| 03/05/2015 | WO2015028669A1 Analogues of porphyrins, their method of preparation and use thereof especially in dye-sensitive solar cells |
| 03/05/2015 | WO2015028622A1 Pyrido[4,3-b]pyrazine compounds and compositions |
| 03/05/2015 | WO2015028574A1 Compound and method for vaccination and immunisation |
| 03/05/2015 | WO2015028455A1 Antibodies |
| 03/05/2015 | WO2015028444A1 Anti cd30 chimeric antigen receptor and its use |
| 03/05/2015 | WO2015028409A1 6,7-dihydro-5h-benzo[7]annulene derivatives, method for the preparation thereof, pharmaceutical preparations comprising them, and the use thereof for producing medicaments |
| 03/05/2015 | WO2015028172A1 Compound of glycosaminoglycan, preparation method and use thereof |
| 03/05/2015 | WO2015027959A1 Cyclic peptide compound, and preparation method, pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027915A1 In-vivo individualized system immunological therapeutic method and device |
| 03/05/2015 | WO2015027914A1 Substituted naphthyridine-2-one compound, preparation method, use and pharmaceutical composition |
| 03/05/2015 | WO2015027863A1 Applications of substituent benzyloxy group containing ether compounds for preparing antitumor drugs |
| 03/05/2015 | WO2015027669A2 Phenyl-substituted compound, pharmaceutical composition and uses thereof |
| 03/05/2015 | WO2015027667A1 2, 6-di-nitrogen-containing substituted purine derivative, and preparation method, pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027438A1 Traditional chinese medicine capable of triggering lung adenocarcinoma cell autophagy, and composition and extract thereof |
| 03/04/2015 | EP2843048A1 NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF |
| 03/04/2015 | EP2842964A1 Virtual method of determining a modified mRNA sequence |
| 03/04/2015 | EP2842961A1 New carbamate glycolipid and use thereof |
| 03/04/2015 | EP2842956A1 PARP inhibitor compounds, compositions and methods of use |
| 03/04/2015 | EP2842950A1 Method for producing composition containing fucoxanthin |
| 03/04/2015 | EP2842949A1 Analogues of porphyrins, their method of preparation and use thereof especially in dye-sensitive solar cells |
| 03/04/2015 | EP2842946A1 Quinazolinedione derivative |
| 03/04/2015 | EP2842939A1 Benzamide derivative |
| 03/04/2015 | EP2842605A2 Use of non-peptide nk1 receptor antagonists for the production of apoptosis in tumor cells |
| 03/04/2015 | EP2842571A1 Antibodies directed to GPNMB and uses thereof |
| 03/04/2015 | EP2841604A1 Assays, methods and apparatus for assessing rna disruption |
| 03/04/2015 | EP2841579A1 Microrna compounds and methods for modulating mir-21 activity |
| 03/04/2015 | EP2841558A1 Oncolytic clostridium ghonii strains, and methods of production and use |
| 03/04/2015 | EP2841459A1 Anti-cd22 antibodies |
| 03/04/2015 | EP2841454A1 Anti-pdgf-c antibodies |
| 03/04/2015 | EP2841417A1 Synthesis of lactams |
| 03/04/2015 | EP2841099A1 Combination of cd37 antibodies with bendamustine |
| 03/04/2015 | EP2841086A1 Compositions and methods for inhibiting the activity of lar family phosphatases |
| 03/04/2015 | EP2841069A1 Highly pure pyrroloquinolinyl-pyrrole-2,5-dione and pyrroloquinolinyl-pyrrolidine-2,5-dione and methods of preparing same |
| 03/03/2015 | US8969406 Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same |
| 03/03/2015 | US8969313 Methods and compounds for preventing and treating a tumour |
| 03/03/2015 | US8969311 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide |
| 03/03/2015 | US8969303 Tocotrienol esters |
| 03/03/2015 | US8969300 Na-K pump modulation |
| 02/26/2015 | WO2015027205A1 Compositions comprising vitamin b12 and intrinsic factor and methods of use thereof |
| 02/26/2015 | WO2015027146A1 Inhibitors of human 12/15-lipoxygenase |
| 02/26/2015 | WO2015027125A1 Multiple myeloma treatment |
| 02/26/2015 | WO2015027124A1 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
| 02/26/2015 | WO2015027121A2 Cancer treatment |
| 02/26/2015 | WO2015027082A1 Tgf-beta receptor type ii variants and uses thereof |
| 02/26/2015 | WO2015027021A1 Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| 02/26/2015 | WO2015026907A1 Anti-prlr antibodies and uses thereof |
| 02/26/2015 | WO2015026818A1 Survival benefit in patients with solid tumors with elevated c-reactive protein levels |
| 02/26/2015 | WO2015026684A1 Modulation of tumor immunity |
| 02/26/2015 | WO2015026112A1 Composition containing monoacetyldiglyceride compound as active ingredient for inhibiting blood cancer or metastasis |
| 02/26/2015 | WO2015025940A1 Novel adenovirus and method for promoting growth thereof |
| 02/26/2015 | WO2015025936A1 Novel quinoline-substituted compound |
| 02/26/2015 | WO2015025786A1 HUMAN ANTIBODY κ TYPE LIGHT CHAIN COMPLEX-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME |
| 02/26/2015 | WO2015025172A1 5-aryl-thiazol-2-yl-amine compounds and their therapeutic use |
| 02/26/2015 | WO2015024986A1 INHIBITION OF A lncRNA FOR TREATMENT OF MELANOMA |
| 02/26/2015 | WO2015024905A1 Derivatives of 1 h-pyrazolo[3,4-b]pyridine and pharmaceutical compositions thereof for the treatment of proliferative disorders |
| 02/26/2015 | WO2015024512A1 Use of icaritin in preparation of drugs for treatment of diseases related to flt-3 |
| 02/26/2015 | WO2015024450A1 Lhrh antagonist derivative and pharmaceutical use thereof |
| 02/26/2015 | WO2015024274A1 Gold nanoflower structure and gold nanoflower/quantum dot composite probe for living cell immunofluorescent labeling and photothermal therapy |
| 02/26/2015 | WO2015024148A1 Vaccine from cell factor mutant of heterogeneous animal |
| 02/26/2015 | WO2015024111A1 Compounds for the treatment of hormone-dependent diseases |
| 02/26/2015 | WO2015024060A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/26/2015 | WO2015024042A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/26/2015 | WO2014006217A9 Dimeric protein with triple mutations |
| 02/25/2015 | EP2840081A1 Use of a novel aminopyridine derivative to prevent or treat cancer |
| 02/25/2015 | EP2840080A1 Nitrogen-containing heterocyclic compound or salt thereof |
| 02/25/2015 | EP2839860A1 Pyrrolobenzodiazepines and conjugates thereof |
| 02/25/2015 | EP2839837A1 Oncolytic Farmington rhabdovirus |
| 02/25/2015 | EP2839037A1 Biomarkers to identify patients that will respond to treatment and treating such patients |
| 02/25/2015 | EP2839015A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids |
| 02/25/2015 | EP2839002A2 Compositions comprising an internalizing nucleic acid molecule, and their methods of use |
| 02/25/2015 | EP2838913A1 Sodium channel sensitive conopeptides and analogs, including compositions and methods thereof |
| 02/25/2015 | EP2838910A1 Replication-competent vesicular stomatitis viruses |
| 02/25/2015 | EP2838906A1 Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors |
| 02/25/2015 | EP2838899A1 Thiazolidinedione derivatives, preparation thereof and use thereof in cancer treatment |
| 02/25/2015 | EP2838881A1 Isoindolone derivatives |
| 02/25/2015 | EP2838879A1 Deuterated rigosertib |
| 02/25/2015 | EP2838561A1 Combination therapy of anti-mif antibodies and chemotherapeutics |
| 02/25/2015 | EP2838519A2 Methods and compounds for treating proliferative disorders and viral infections |
| 02/24/2015 | US8962637 Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors |
| 02/24/2015 | US8962630 Pyrrolopyrimidine compounds and their uses |
| 02/24/2015 | US8962620 Substituted 6,5-fused bicyclic heteroaryl compounds |